Neurofibromatosis Type 1 Alternative Splicing Is a Key Regulator of Ras Signaling in Neurons

REFERENCES

• Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. 2009. Neurofibromatosis type 1 revisited. Pediatrics 123:124–133. http://dx.doi.org/10.1542/peds.2007-3204.
   PubMed Web of Science ®Google Scholar
• Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F. 1990. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851–859. http://dx.doi.org/10.1016/0092-8674(90)90151-4.
   PubMed Web of Science ®Google Scholar
• Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O'Connell P, Cawthon RM. 1990. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–849. http://dx.doi.org/10.1016/0092-8674(90)90150-D.
   PubMed Web of Science ®Google Scholar
• Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F. 1990. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63:835–841. http://dx.doi.org/10.1016/0092-8674(90)90149-9.
   PubMed Web of Science ®Google Scholar
• DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR. 1992. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265–273. http://dx.doi.org/10.1016/0092-8674(92)90407-4.
   PubMedGoogle Scholar
• Le LQ, Parada LF. 2007. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 26:4609–4616. http://dx.doi.org/10.1038/sj.onc.1210261.
   PubMedGoogle Scholar
• Gutmann DH, Parada LF, Silva AJ, Ratner N. 2012. Neurofibromatosis type 1: modeling CNS dysfunction. J. Neurosci. 32:14087–14093. http://dx.doi.org/10.1523/JNEUROSCI.3242-12.2012.
   PubMed Web of Science ®Google Scholar
• Diggs-Andrews KA, Gutmann DH. 2013. Modeling cognitive dysfunction in neurofibromatosis-1. Trends Neurosci. 36:237–247. http://dx.doi.org/10.1016/j.tins.2012.12.002.
   PubMedGoogle Scholar
• Xu W, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CG, Ponder BA. 1992. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer 4:337–342. http://dx.doi.org/10.1002/gcc.2870040411.
   PubMed Web of Science ®Google Scholar
• Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599–608. http://dx.doi.org/10.1016/0092-8674(90)90024-9.
   PubMed Web of Science ®Google Scholar
• Tong J, Hannan F, Zhu Y, Bernards A, Zhong Y. 2002. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat. Neurosci. 5:95–96. http://dx.doi.org/10.1038/nn792.
   PubMed Web of Science ®Google Scholar
• Dasgupta B, Dugan LL, Gutmann DH. 2003. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes. J. Neurosci. 23:8949–8954.
   PubMed Web of Science ®Google Scholar
• The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Gusella JF, Hariharan IK, Bernards A. 1997. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 276:791–794. http://dx.doi.org/10.1126/science.276.5313.791.
   PubMedGoogle Scholar
• Hirvonen O, Lakkakorpi J, Aaltonen V, Hirvonen H, Rossi M, Karvonen SL, Yla-Outinen H, Kalimo H, Peltonen J. 1998. Developmental regulation of NF1 tumor suppressor gene in human peripheral nerve. J. Neurocytol. 27:939–952. http://dx.doi.org/10.1023/A:1006905224474.
   PubMedGoogle Scholar
• Daston MM, Ratner N. 1992. Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev. Dyn. 195:216–226. http://dx.doi.org/10.1002/aja.1001950307.
   PubMed Web of Science ®Google Scholar
• Daston MM, Scrable H, Nordlund M, Sturbaum AK, Nissen LM, Ratner N. 1992. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 8:415–428. http://dx.doi.org/10.1016/0896-6273(92)90270-N.
   PubMed Web of Science ®Google Scholar
• Gutmann DH, Wood DL, Collins FS. 1991. Identification of the neurofibromatosis type 1 gene product. Proc. Natl. Acad. Sci. U. S. A. 88:9658–9662. http://dx.doi.org/10.1073/pnas.88.21.9658.
   PubMedGoogle Scholar
• Gutmann DH, Geist RT, Wright DE, Snider WD. 1995. Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. Cell Growth Differ. 6:315–323.
   PubMedGoogle Scholar
• Golubic M, Roudebush M, Dobrowolski S, Wolfman A, Stacey DW. 1992. Catalytic properties, tissue and intracellular distribution of neurofibromin. Oncogene 7:2151–2159.
   PubMed Web of Science ®Google Scholar
• Bernards A, Snijders AJ, Hannigan GE, Murthy AE, Gusella JF. 1993. Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and non-coding mRNA segments. Hum. Mol. Genet. 2:645–650. http://dx.doi.org/10.1093/hmg/2.6.645.
   PubMedGoogle Scholar
• Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg AM, Jenkins NA, Parada LF, Copeland NG. 1994. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8:1019–1029. http://dx.doi.org/10.1101/gad.8.9.1019.
   PubMed Web of Science ®Google Scholar
• Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat. Genet. 7:353–361. http://dx.doi.org/10.1038/ng0794-353.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Romero MI, Ghosh P, Ye Z, Charnay P, Rushing EJ, Marth JD, Parada LF. 2001. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15:859–876. http://dx.doi.org/10.1101/gad.862101.
   PubMedGoogle Scholar
• Brown JA, Emnett RJ, White CR, Yuede CM, Conyers SB, O'Malley KL, Wozniak DF, Gutmann DH. 2010. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum. Mol. Genet. 19:4515–4528. http://dx.doi.org/10.1093/hmg/ddq382.
   PubMed Web of Science ®Google Scholar
• Brown JA, Gianino SM, Gutmann DH. 2010. Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity. J. Neurosci. 30:5579–5589. http://dx.doi.org/10.1523/JNEUROSCI.3994-09.2010.
   PubMed Web of Science ®Google Scholar
• Brown JA, Diggs-Andrews KA, Gianino SM, Gutmann DH. 2012. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner. Mol. Cell. Neurosci. 49:13–22. http://dx.doi.org/10.1016/j.mcn.2011.08.008.
   PubMedGoogle Scholar
• Silva AJ, Frankland PW, Marowitz Z, Friedman E, Laszlo GS, Cioffi D, Jacks T, Bourtchuladze R. 1997. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat. Genet. 15:281–284. http://dx.doi.org/10.1038/ng0397-281.
   PubMed Web of Science ®Google Scholar
• Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ. 2002. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415:526–530. http://dx.doi.org/10.1038/nature711.
   PubMed Web of Science ®Google Scholar
• Wang Y, Nicol GD, Clapp DW, Hingtgen CM. 2005. Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability. J. Neurophysiol. 94:3670–3676. http://dx.doi.org/10.1152/jn.00489.2005.
   PubMedGoogle Scholar
• Hingtgen CM. 2008. Neurofibromatosis: the role of guanosine triphosphatase activating proteins in sensory neuron function. Acta Physiol. Sin. 60:581–583.
   PubMedGoogle Scholar
• Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, Cannon TD, Silva AJ. 2005. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr. Biol. 15:1961–1967. http://dx.doi.org/10.1016/j.cub.2005.09.043.
   PubMed Web of Science ®Google Scholar
• Mainberger F, Jung NH, Zenker M, Wahllander U, Freudenberg L, Langer S, Berweck S, Winkler T, Straube A, Heinen F, Granstrom S, Mautner VF, Lidzba K, Mall V. 2013. Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1. BMC Neurol. 13:131. http://dx.doi.org/10.1186/1471-2377-13-131.
   PubMedGoogle Scholar
• Diggs-Andrews KA, Tokuda K, Izumi Y, Zorumski CF, Wozniak DF, Gutmann DH. 2013. Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. Ann. Neurol. 73:309–315. http://dx.doi.org/10.1002/ana.23793.
   PubMed Web of Science ®Google Scholar
• Danglot G, Regnier V, Fauvet D, Vassal G, Kujas M, Bernheim A. 1995. Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene. Hum. Mol. Genet. 4:915–920. http://dx.doi.org/10.1093/hmg/4.5.915.
   PubMedGoogle Scholar
• Bernards A, Haase VH, Murthy AE, Menon A, Hannigan GE, Gusella JF. 1992. Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and absence of expression in a neuroblastoma line. DNA Cell Biol. 11:727–734. http://dx.doi.org/10.1089/dna.1992.11.727.
   PubMedGoogle Scholar
• Gutmann DH, Zhang Y, Hirbe A. 1999. Developmental regulation of a neuron-specific neurofibromatosis 1 isoform. Ann. Neurol. 46:777–782. http://dx.doi.org/10.1002/1531-8249(199911)46:5<777::AID-ANA15>3.0.CO;2-H.
   PubMed Web of Science ®Google Scholar
• Danglot G, Teinturier C, Duverger A, Bernheim A. 1994. Tissue-specific alternative splicing of neurofibromatosis 1 (NF1) mRNA. Biomed. Pharmacother. 48:365–372. http://dx.doi.org/10.1016/0753-3322(94)90053-1.
   PubMedGoogle Scholar
• Gutmann DH, Geist RT, Rose K, Wright DE. 1995. Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev. Dyn. 202:302–311. http://dx.doi.org/10.1002/aja.1002020309.
   PubMed Web of Science ®Google Scholar
• Gutman DH, Andersen LB, Cole JL, Swaroop M, Collins FS. 1993. An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle. Hum. Mol. Genet. 2:989–992. http://dx.doi.org/10.1093/hmg/2.7.989.
   PubMedGoogle Scholar
• Geist RT, Gutmann DH. 1996. Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci. Lett. 211:85–88. http://dx.doi.org/10.1016/0304-3940(96)12730-0.
   PubMedGoogle Scholar
• Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, Camonis J, Wigler M, Collins FS. 1993. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol. Cell. Biol. 13:487–495.
   PubMedGoogle Scholar
• Gutmann DH, Cole JL, Collins FS. 1995. Expression of the neurofibromatosis type 1 (NF1) gene during mouse embryonic development. Prog. Brain Res. 105:327–335. http://dx.doi.org/10.1016/S0079-6123(08)63311-7.
   PubMedGoogle Scholar
• Suzuki Y, Suzuki H, Kayama T, Yoshimoto T, Shibahara S. 1991. Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. Biochem. Biophys. Res. Commun. 181:955–961. http://dx.doi.org/10.1016/0006-291X(91)92029-J.
   PubMedGoogle Scholar
• Mantani A, Wakasugi S, Yokota Y, Abe K, Ushio Y, Yamamura K. 1994. A novel isoform of the neurofibromatosis type-1 mRNA and a switch of isoforms during murine cell differentiation and proliferation. Gene 148:245–251. http://dx.doi.org/10.1016/0378-1119(94)90695-5.
   PubMedGoogle Scholar
• Huynh DP, Nechiporuk T, Pulst SM. 1994. Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev. Biol. 161:538–551. http://dx.doi.org/10.1006/dbio.1994.1052.
   PubMedGoogle Scholar
• Metheny LJ, Skuse GR. 1996. NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors. Exp. Cell Res. 228:44–49. http://dx.doi.org/10.1006/excr.1996.0297.
   PubMedGoogle Scholar
• Barron VA, Lou H. 2012. Alternative splicing of the neurofibromatosis type I pre-mRNA. Biosci. Rep. 32:131–138. http://dx.doi.org/10.1042/BSR20110060.
   PubMedGoogle Scholar
• Barron VA, Zhu H, Hinman MN, Ladd AN, Lou H. 2010. The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation. Nucleic Acids Res. 38:253–264. http://dx.doi.org/10.1093/nar/gkp766.
   PubMed Web of Science ®Google Scholar
• Fleming VA, Geng C, Ladd AN, Lou H. 2012. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors. BMC Mol. Biol. 13:35. http://dx.doi.org/10.1186/1471-2199-13-35.
   PubMedGoogle Scholar
• Zhou HL, Hinman MN, Barron VA, Geng C, Zhou G, Luo G, Siegel RE, Lou H. 2011. Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 108:E627–E635. http://dx.doi.org/10.1073/pnas.1103344108.
   PubMed Web of Science ®Google Scholar
• Zhu H, Hinman MN, Hasman RA, Mehta P, Lou H. 2008. Regulation of neuron-specific alternative splicing of neurofibromatosis type 1 pre-mRNA. Mol. Cell. Biol. 28:1240–1251. http://dx.doi.org/10.1128/MCB.01509-07.
   PubMed Web of Science ®Google Scholar
• Yunoue S, Tokuo H, Fukunaga K, Feng L, Ozawa T, Nishi T, Kikuchi A, Hattori S, Kuratsu J, Saya H, Araki N. 2003. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. J. Biol. Chem. 278:26958–26969. http://dx.doi.org/10.1074/jbc.M209413200.
   PubMed Web of Science ®Google Scholar
• Costa RM, Yang T, Huynh DP, Pulst SM, Viskochil DH, Silva AJ, Brannan CI. 2001. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat. Genet. 27:399–405. http://dx.doi.org/10.1038/86898.
   PubMed Web of Science ®Google Scholar
• Bibel M, Richter J, Lacroix E, Barde YA. 2007. Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat. Protoc. 2:1034–1043. http://dx.doi.org/10.1038/nprot.2007.147.
   PubMed Web of Science ®Google Scholar
• Lou H, Yang Y, Cote GJ, Berget SM, Gagel RF. 1995. An intron enhancer containing a 5′ splice site sequence in the human calcitonin/calcitonin gene-related peptide gene. Mol. Cell. Biol. 15:7135–7142.
   PubMedGoogle Scholar
• Hinman MN, Zhou HL, Sharma A, Lou H. 2013. All three RNA recognition motifs and the hinge region of HuC play distinct roles in the regulation of alternative splicing. Nucleic Acids Res. 41:5049–5061. http://dx.doi.org/10.1093/nar/gkt166.
   PubMedGoogle Scholar
• Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 90:8424–8428. http://dx.doi.org/10.1073/pnas.90.18.8424.
   PubMed Web of Science ®Google Scholar
• Bouck J, Litwin S, Skalka AM, Katz RA. 1998. In vivo selection for intronic splicing signals from a randomized pool. Nucleic Acids Res. 26:4516–4523. http://dx.doi.org/10.1093/nar/26.19.4516.
   PubMedGoogle Scholar
• Coolidge CJ, Seely RJ, Patton JG. 1997. Functional analysis of the polypyrimidine tract in pre-mRNA splicing. Nucleic Acids Res. 25:888–896. http://dx.doi.org/10.1093/nar/25.4.888.
   PubMedGoogle Scholar
• Bouck J, Fu XD, Skalka AM, Katz RA. 1995. Genetic selection for balanced retroviral splicing: novel regulation involving the second step can be mediated by transitions in the polypyrimidine tract. Mol. Cell. Biol. 15:2663–2671.
   PubMedGoogle Scholar
• Roscigno RF, Weiner M, Garcia-Blanco MA. 1993. A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem. 268:11222–11229.
   PubMedGoogle Scholar
• Singh R, Valcarcel J, Green MR. 1995. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268:1173–1176. http://dx.doi.org/10.1126/science.7761834.
   PubMed Web of Science ®Google Scholar
• Lush ME, Li Y, Kwon CH, Chen J, Parada LF. 2008. Neurofibromin is required for barrel formation in the mouse somatosensory cortex. J. Neurosci. 28:1580–1587. http://dx.doi.org/10.1523/JNEUROSCI.5236-07.2008.
   PubMedGoogle Scholar
• Guilding C, McNair K, Stone TW, Morris BJ. 2007. Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB. Eur. J. Neurosci. 25:99–105. http://dx.doi.org/10.1111/j.1460-9568.2006.05238.x.
   PubMedGoogle Scholar
• Moroy T, Heyd F. 2007. The impact of alternative splicing in vivo: mouse models show the way. RNA 13:1155–1171. http://dx.doi.org/10.1261/rna.554607.
   PubMedGoogle Scholar
• Scheffzek K, Ahmadian MR, Wiesmuller L, Kabsch W, Stege P, Schmitz F, Wittinghofer A. 1998. Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J. 17:4313–4327. http://dx.doi.org/10.1093/emboj/17.15.4313.
   PubMedGoogle Scholar
• Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, Parada LF, Mody I, Silva AJ. 2008. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135:549–560. http://dx.doi.org/10.1016/j.cell.2008.09.060.
   PubMed Web of Science ®Google Scholar
• Peng S, Zhang Y, Zhang J, Wang H, Ren B. 2010. ERK in learning and memory: a review of recent research. Int. J. Mol. Sci. 11:222–232. http://dx.doi.org/10.3390/ijms11010222.
   PubMed Web of Science ®Google Scholar